This is a branch carrying out diagnosis and treatment of diseases with the use of radioactive substances and providing many organ and tissue to be displayed in this way.

Radioactive substances used for diagnosis are different property for each organ and they are used in assessment of the structure of the organs and organ functions with emitted rays. After these substances are given to the patients, films taken are called as scintigraphy.

Such as Thyroid scintigraphy, Poratiroid scintigraphy, myocardial perfusion scintigraphy, gated myocardial perfusion scintigraphy, renal parenchyma and function scintigraphy, bone scintigraphy, Gastroösefajial reflux scintigraphy, liver blood pool (hemangioma) scintigraphy, lung perfusion / ventilation scintigraphy, tumor imaging with Octreotide, tumor displaying with MIGB, Lymphoscintigraphy ...

In addition to diagnostic studies, treatment applications are carried out in the department of nuclear medicine in the Private Gaziosmanpasa Hospital. High dose radioactive medicines are used for the purpose of treatment by benefiting from the characteristic of private radioactive medicines being kept in target organ. Toxic guatr treatment, relieving of common pains in advanced cancer disease may be given to this subject.

Time of images to be taken in scintigraphy differs from examination to examination. About these times, detailed information is given to the patients in the department of nuclear medicine.

PET CT

It is a non-invasive (non-interventional) cross-sectional displaying method consistng of combination of Pet (Pozitron Emission Tomography) and BT (Computerized Tomography) devices.

PET/BT is a device consisting of combination of hybrid/two displaying device, in which special medicines sensitive to changes at the metabolism level not forming structural changes in patient tissues are used.

Positron-emitting radionuclides labeled medicines are injected intra venal to the patients before this displaying process. F-18FDG (fluorodeoxyglucose) used commonly in the world from these medicines in our world is the most widely used radiopharmaceutical (radionuclide-labeled drugs). These medicines are medicines containing radiation at very low level and not having any side effect proven in patients.

Due to uncontrolled cell division in tumor tissue, assessment is made in accordance with determination of increased uptake according to normal healthy cells in tumor cells of FDG (fluorodeoxyglucose), which is a glucose type including in medicament given by us due to glucose need increasing according to normal healthy cells.

Due to uncontrolled cell division in tumor tissue, assessment is made in accordance with determination of increased uptake according to normal healthy cells in tumor cells of FDG (fluorodeoxyglucose), which is a glucose type including in medicament given by us due to glucose need increasing according to normal healthy cells.

In separation of bulks having cancer suspicion whether they are good/bad tempered, in determination of the extent of disease in patients from whom cancer diagnosis is taken, in determination of response to the treatment on the cancer follow-up phase in patients, rom whom cancer diagnosis have been taken or in detection of cancer reoccurrence is used.

In assessment of epilepsy patients planned to be operated out of oncology and diagnosis of Alzheimer’s disease, in assessment of presence of viability (living tissue) in the previous infarction (heart attack) undergone on myocardial (heart muscle) tissue is used. In our hospital, SIEMENS biography mCT PET/BT established for this purpose is latest technology device, whose part of PET has volumetric resolution of 87 mm3 and 2 mm, whose BT part gives a very good image quality in very low radiation doses, which has ultraHD imaging quality. Our hospital gives service about this subject with its specialized and experienced team.